ETON

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is a specialty pharmaceutical company founded in 2017 and based in Deer Park, Illinois. The company went public in November 2018 and focuses on developing and commercializing pharmaceutical products for rare diseases, particularly those affecting fewer than 10,000 patients in the United States. Since its inception, Eton has transformed from a development-stage company into a commercial enterprise with multiple approved products, achieving consistent revenue growth and reaching near-profitability by 2024.